pmid,title,journal,year,drug,disease
40868984,Angiotensin-Converting Enzyme Inhibition and/or Angiotensin Receptor Blockade Modulate Cytokine Profiles and Improve Clinical Outcomes in Experimental COVID-19 Infection.,International journal of molecular sciences,2025,Losartan,SARS-CoV-2
39979403,QbD-steered HPTLC approach for concurrent estimation of six co-administered COVID-19 and cardiovascular drugs in different matrices: greenness appraisal.,Scientific reports,2025,Losartan,SARS-CoV-2
39805853,Dysregulated autoantibodies targeting AGTR1 are associated with the accumulation of COVID-19 symptoms.,NPJ systems biology and applications,2025,Losartan,SARS-CoV-2
39603070,A Glimpse for the subsistence from pandemic SARS-CoV-2 infection.,Bioorganic chemistry,2025,Losartan,SARS-CoV-2
39481808,Design and rationale of MYOFLAME-19 randomised controlled trial: MYOcardial protection to reduce post-COVID inFLAMmatory heart disease using cardiovascular magnetic resonance Endpoints.,Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance,2025,Losartan,SARS-CoV-2
39433817,Losartan and enalapril maleate differently influence SARS-CoV-2-infected vero cells.,Scientific reports,2024,Losartan,SARS-CoV-2
39416971,Evaluation of Angiotensin-Converting Enzyme 2 Expression In Vivo with Novel (68)Ga-Labeled Peptides Originated from the Coronavirus Receptor-Binding Domain.,ACS pharmacology & translational science,2024,Losartan,SARS-CoV-2
39354270,SARS-CoV-2 Spike Protein Exacerbates Thromboembolic Cerebrovascular Complications in Humanized ACE2 Mouse Model.,Translational stroke research,2025,Losartan,SARS-CoV-2
39325643,Effects of Losartan on Patients Hospitalized for Acute COVID-19: A Randomized Controlled Trial.,Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,2024,Losartan,SARS-CoV-2
39074114,Timing matters in the use of renin-angiotensin system modulators and COVID-related cognitive and cerebrovascular dysfunction.,PloS one,2024,Losartan,SARS-CoV-2
38959647,Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019.,Bioorganic chemistry,2024,Losartan,SARS-CoV-2
38828744,Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies.,Expert opinion on therapeutic targets,2024,Losartan,SARS-CoV-2
38664510,Relationship between 2nd-generation angiotensin receptor blockers and the risk of hypotension in COVID-19 patients admitted to hospital.,Hypertension research : official journal of the Japanese Society of Hypertension,2024,Losartan,SARS-CoV-2
37661180,Perindopril and losartan attenuate pro-coagulation factors in human adipocytes exposed to SARS-CoV-2 spike protein.,Journal of physiology and pharmacology : an official journal of the Polish Physiological Society,2023,Losartan,SARS-CoV-2
36908454,Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data.,Frontiers in public health,2023,Losartan,SARS-CoV-2
36750199,COVID-19: Understanding the impact of anti-hypertensive drugs and hydroxychloroquine on the ACE1 and ACE2 in lung and adipose tissue in SHR and WKY rats.,Physiological reports,2023,Losartan,SARS-CoV-2
36740128,"Repurposing of US-FDA approved drugs against SARS-CoV-2 main protease (M(pro)) by using STD-NMR spectroscopy, in silico studies and antiviral assays.",International journal of biological macromolecules,2023,Losartan,SARS-CoV-2
36551182,Structure-Based Virtual Screening and Functional Validation of Potential Hit Molecules Targeting the SARS-CoV-2 Main Protease.,Biomolecules,2022,Losartan,SARS-CoV-2
35874909,COVIDMED - An early pandemic randomized clinical trial of losartan treatment for hospitalized COVID-19 patients.,Contemporary clinical trials communications,2022,Losartan,SARS-CoV-2
35867861,SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction.,Brain : a journal of neurology,2023,Losartan,SARS-CoV-2
35794497,Bioactive components of different nasal spray solutions may defeat SARS-Cov2: repurposing and in silico studies.,Journal of molecular modeling,2022,Losartan,SARS-CoV-2
35432786,Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2.,Computational and structural biotechnology journal,2022,Losartan,SARS-CoV-2
35359831,"Oral Lisinopril Raises Tissue Levels of ACE2, the SARS-CoV-2 Receptor, in Healthy Male and Female Mice.",Frontiers in pharmacology,2022,Losartan,SARS-CoV-2
35305551,Does Losartan reduce the severity of COVID-19 in hypertensive patients?,BMC cardiovascular disorders,2022,Losartan,SARS-CoV-2
35294537,Efficacy of Losartan in Hospitalized Patients With COVID-19-Induced Lung Injury: A Randomized Clinical Trial.,JAMA network open,2022,Losartan,SARS-CoV-2
35153802,Commentary: Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.,Frontiers in pharmacology,2022,Losartan,SARS-CoV-2
35106453,Attenuation of SARS-CoV-2 infection by losartan in human kidney organoids.,iScience,2022,Losartan,SARS-CoV-2
34965651,Comment on 'Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial'.,International journal of clinical practice,2021,Losartan,SARS-CoV-2
34937861,Correlation of ACE2 with RAS components after Losartan treatment in light of COVID-19.,Scientific reports,2021,Losartan,SARS-CoV-2
34867390,Effect of Angiotensin-Converting-Enzyme Inhibitor and Angiotensin II Receptor Antagonist Treatment on ACE2 Expression and SARS-CoV-2 Replication in Primary Airway Epithelial Cells.,Frontiers in pharmacology,2021,Losartan,SARS-CoV-2
34646263,Preliminary Evidence for IL-10-Induced ACE2 mRNA Expression in Lung-Derived and Endothelial Cells: Implications for SARS-Cov-2 ARDS Pathogenesis.,Frontiers in immunology,2021,Losartan,SARS-CoV-2
34631362,Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex.,In silico pharmacology,2021,Losartan,SARS-CoV-2
34585129,Outpatient and inpatient anticoagulation therapy and the risk for hospital admission and death among COVID-19 patients.,EClinicalMedicine,2021,Losartan,SARS-CoV-2
34529856,Occurrence of Pharmaceutically Active Compounds and Potential Ecological Risks in Wastewater from Hospitals and Receiving Waters in Sri Lanka.,Environmental toxicology and chemistry,2022,Losartan,SARS-CoV-2
34525378,Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells.,Stem cell reports,2021,Losartan,SARS-CoV-2
34319871,Losartan Inhibits SARS-CoV-2 Replication in Vitro.,"Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques",2021,Losartan,SARS-CoV-2
34234323,COVID and the brain: researchers zero in on how damage occurs.,Nature,2021,Losartan,SARS-CoV-2
34195577,A multi-center phase II randomized clinical trial of losartan on symptomatic outpatients with COVID-19.,EClinicalMedicine,2021,Losartan,SARS-CoV-2
34064039,"The Molecular Basis of COVID-19 Pathogenesis, Conventional and Nanomedicine Therapy.",International journal of molecular sciences,2021,Losartan,SARS-CoV-2
33977506,Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia.,Infectious diseases and therapy,2021,Losartan,SARS-CoV-2
33850936,Present and future treatment strategies for coronavirus disease 2019.,Future journal of pharmaceutical sciences,2021,Losartan,SARS-CoV-2
33650197,Comparison of losartan and amlodipine effects on the outcomes of patient with COVID-19 and primary hypertension: A randomised clinical trial.,International journal of clinical practice,2021,Losartan,SARS-CoV-2
33614058,Immunoglobulin-A Vasculitis With Renal Involvement in a Patient With COVID-19: A Case Report and Review of Acute Kidney Injury Related to SARS-CoV-2.,Canadian journal of kidney health and disease,2021,Losartan,SARS-CoV-2
33566370,A pressor dose of angiotensin II has no influence on the angiotensin-converting enzyme 2 and other molecules associated with SARS-CoV-2 infection in mice.,FASEB journal : official publication of the Federation of American Societies for Experimental Biology,2021,Losartan,SARS-CoV-2
33504092,From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy.,"Molecules (Basel, Switzerland)",2021,Losartan,SARS-CoV-2
33378401,"Safety, tolerability, and outcomes of losartan use in patients hospitalized with SARS-CoV-2 infection: A feasibility study.",PloS one,2020,Losartan,SARS-CoV-2
33314219,mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.,Journal of medical virology,2021,Losartan,SARS-CoV-2
33294721,"Molecular docking, molecular dynamics, and in vitro studies reveal the potential of angiotensin II receptor blockers to inhibit the COVID-19 main protease.",Heliyon,2020,Losartan,SARS-CoV-2
33293316,"Study protocol for a multicentre, prospective cohort study of the association of angiotensin II type 1 receptor blockers on outcomes of coronavirus infection.",BMJ open,2020,Losartan,SARS-CoV-2
33260370,Repositioning of Ligands That Target the Spike Glycoprotein as Potential Drugs for SARS-CoV-2 in an In Silico Study.,"Molecules (Basel, Switzerland)",2020,Losartan,SARS-CoV-2
